Prosecution Insights
Last updated: October 27, 2026

Katerina Anna Wittliff, USPTO Patent Examiner

Listed by the USPTO as WITTLIFF, KATERINA ANNA

Tech Center 3700 • Art Units: 2841 3746 3783 3792

This examiner grants 35% of resolved cases

Analysis

WITTLIFF, KATERINA ANNA has resolved 20 cases in tech center 3700 and art unit 2841. The allowance rate is 35.0%, and the median time to allowance is 1401 days. The interview lift is 18.8%, indicating a positive association in a small case history.

The listed companies are Cardinal Health Inc., Becton, Dickinson and Company, and Amgen Inc. The listed firms are Knobbe, Martens, Olson & Bear, LLP, Maschoff Brennan (OC)(BD), and GREER, BURNS & CRAIN, LTD. The limited number of resolved cases calls for caution in generalizing, while the low allowance rate and long median timeline support close prosecution planning.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

35.0%
Allow Rate
-35.0% vs TC avg
76
Total Applications
+18.8%
Interview Lift
1401
Avg Prosecution Days
Based on 20 resolved cases, 2023–2026

Rejection Statute Breakdown

1.6%
§101 Eligibility
23.0%
§102 Novelty
54.1%
§103 Obviousness
19.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17949734 Introducer Adapters, Introducer Assemblies, and Methods Non-Final OA Bard Access Systems, Inc.
18057258 CATHETER Final Rejection TERUMO KABUSHIKI KAISHA
17980090 SYRINGE WITH BIASING MEMBER Non-Final OA CareFusion 303, Inc.
17895887 SINGLE MONOLITHIC PIECE PIVC-INTEGRATED HEMOLYSIS-REDUCTION ACCESSORIES FOR DIRECT BLOOD DRAW Non-Final OA CareFusion 303, Inc.
17573582 SYSTEM AND METHOD FOR REDUCED INFUSION ADMINISTRATION LINE ERROR Final Rejection CareFusion 303, Inc.
18853083 METHOD AND SYSTEM FOR MONITORING A WASTE STREAM TO INCREASE EFFICIENCY OF A SURGICAL IRRIGATION PROCEDURE Non-Final OA CareFusion 2200, Inc.
18740828 METHODS AND APPARATUS FOR SUBRETINAL DELIVERY Non-Final OA Alcon Inc.
18231997 Clip on Torque Device for Endovascular Procedures Final Rejection Wisconsin Alumni Research Foundation
17630219 CATHETER HAVING CONNECTOR WITH ELECTRICAL CONDUCTOR CONNECTIONS Non-Final OA BIOTRONIK AG
18684914 INSUFFLATOR SAFETY VALVE HAVING ELECTRICALLY VARIABLE CRACKING PRESSURE Final Rejection Conmed Corporation
18207618 SAFE OPERATION OF INTEGRATED NEGATIVE PRESSURE WOUND TREATMENT APPARATUSES Non-Final OA Smith & Nephew PLC
17963813 Low-Profile Single and Dual Vascular Access Device Non-Final OA C. R. Bard, Inc.
17770341 DRUG DELIVERY DEVICE AND SYSTEM Non-Final OA AMGEN INC.
17767469 DRUG DELIVERY DEVICE AND SYSTEM Final Rejection AMGEN INC.
17852574 Protective Cover for a Medical Device Non-Final OA Becton, Dickinson and Company
17852526 Non-Integrated Catheter System Having an Extension Set Final Rejection Becton, Dickinson and Company
17851641 Instrument Advancement Device Configured for Septum Engagement Non-Final OA Becton, Dickinson and Company
17851666 Vascular Access Device with Non-Contact Guidewire Advancement Non-Final OA Becton, Dickinson and Company
17828794 Compositions And Methods For Treating With A Combination Of Alternating Electric Fields And Trastuzumab Final Rejection NOVOCURE GMBH
17763154 Vascular Access Systems and Methods Thereof Non-Final OA Bard Peripheral Vascular, Inc.
18269957 SKIN PATCH DRUG INFUSION DEVICE Final Rejection MEDTRUM TECHNOLOGIES INC.
17924119 UNIDIRECTIONAL-DRIVEN DRUG INFUSION DEVICE Non-Final OA MEDTRUM TECHNOLOGIES INC.
18859696 GASTRIC SECRETION REINFUSION SYSTEM AND METHOD OF OPERATION Non-Final OA THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
17917578 MONITORING FLUID BALANCE Final Rejection ELMEDIX NV
18220857 ENTERAL CONNECTOR Final Rejection Individual inventor

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Katerina Anna Wittliff's allowance rate?

35.0% of resolved applications examined by Katerina Anna Wittliff were allowed (20 resolved cases), compared with 85.1% across Art Unit 2841 over the last five years.

Does an interview help with examiner Katerina Anna Wittliff?

This examiner's interview lift is +18.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Katerina Anna Wittliff take to allow a patent?

Applications allowed by Katerina Anna Wittliff took 1,401 days on average from filing to allowance.

Which art unit does examiner Katerina Anna Wittliff work in?

Katerina Anna Wittliff examines applications in Art Unit 2841 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month